ArticleAnnals of the rheumatic diseases2021

Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry.

Kevin L Winthrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.